Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
European Journal of Medicinal Chemistry
|
November 1, 2020
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid
Maria Grazia Perrone, Morena Miciaccia, Paola Vitale, et al.
European Journal of Medicinal Chemistry
|
July 13, 2025
Hunting for lubeluzole analogues as antimyotonic agents with reduced cardiac liability
Maria Maddalena Cavalluzzi, Roberta Gualdani, Alessandro Farinato, et al.
Journal of Medicinal Chemistry
|
February 20, 2025
ONC201-Derived Tetrahydropyridopyrimidindiones as Powerful ClpP Protease Activators to Tackle Diffuse Midline Glioma
Morena Miciaccia, Olga Maria Baldelli, Cosimo G Fortuna, et al.
Journal of Medicinal Chemistry
|
June 27, 2024
<i>N</i>-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R)
Francesca Intranuovo, Maria Majellaro, Francesco Mastropasqua, et al.
European Journal of Medicinal Chemistry
|
December 28, 2018
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability
Maria Laura Pati, Paola Vitale, Savina Ferorelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 12, 2026
Discovery of bridged melanostatin derivatives as potent allosteric modulators of the dopamine D<sub>2</sub> receptors with improved permeability
Ivo E Sampaio-Dias, Hugo F Costa-Almeida, Xavier C Correia, et al.
Journal of Medicinal Chemistry
|
August 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB<sub>2</sub> Agonists with Neuroprotective Effects
Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz, et al.
Research Square
|
February 6, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids
Antonio Scilimati, Morena Miciaccia, Domenico Armenise, et al.
Journal of Medicinal Chemistry
|
July 8, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids
Morena Miciaccia, Domenico Armenise, Olga Maria Baldelli, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
European Journal of Medicinal Chemistry
|
November 1, 2020
An attempt to chemically state the cross-talk between monomers of COX homodimers by double/hybrid inhibitors mofezolac-spacer-mofezolac and mofezolac-spacer-arachidonic acid
Maria Grazia Perrone, Morena Miciaccia, Paola Vitale, et al.
European Journal of Medicinal Chemistry
|
July 13, 2025
Hunting for lubeluzole analogues as antimyotonic agents with reduced cardiac liability
Maria Maddalena Cavalluzzi, Roberta Gualdani, Alessandro Farinato, et al.
Journal of Medicinal Chemistry
|
February 20, 2025
ONC201-Derived Tetrahydropyridopyrimidindiones as Powerful ClpP Protease Activators to Tackle Diffuse Midline Glioma
Morena Miciaccia, Olga Maria Baldelli, Cosimo G Fortuna, et al.
Journal of Medicinal Chemistry
|
June 27, 2024
<i>N</i>-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R)
Francesca Intranuovo, Maria Majellaro, Francesco Mastropasqua, et al.
European Journal of Medicinal Chemistry
|
December 28, 2018
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability
Maria Laura Pati, Paola Vitale, Savina Ferorelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 12, 2026
Discovery of bridged melanostatin derivatives as potent allosteric modulators of the dopamine D<sub>2</sub> receptors with improved permeability
Ivo E Sampaio-Dias, Hugo F Costa-Almeida, Xavier C Correia, et al.
Journal of Medicinal Chemistry
|
August 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB<sub>2</sub> Agonists with Neuroprotective Effects
Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz, et al.
Research Square
|
February 6, 2026
Dysregulation of human ClpP using small molecules with piperazine-based scaffold for diffuse intrinsic pontine glioma therapy validated by patient-derived tumor organoids
Antonio Scilimati, Morena Miciaccia, Domenico Armenise, et al.
Journal of Medicinal Chemistry
|
July 8, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids
Morena Miciaccia, Domenico Armenise, Olga Maria Baldelli, et al.
Page
of 11